• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Posterior chamber phakic IOLs appear safe for moderate, high myopia

Article

Orlando-Posterior chamber phakic implants can offer safe and effective correction of moderate to high myopia with stable refractive outcomes, low risks of operative and postoperative complications, high patient satisfaction, and the benefit of less induction of optical aberrations relative to LASIK, according to James J. Salz, MD.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.